Related Experiment Video
Updated: May 18, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
The small GTPase RhoG mediates glioblastoma cell invasion
Aneta Kwiatkowska1, Sebastien Didier, Shannon Fortin
1Center for Oncology and Cell Biology, The Feinstein Institute for Medical Research at North Shore-LIJ, Manhasset, NY, USA.
Background:
The invasion of glioblastoma cells into regions of the normal brain is a critical factor that limits current therapies for malignant astrocytomas. Previous work has identified roles for the Rho family guanine nucleotide exchange factors Trio and Vav3 in glioblastoma invasion. Both Trio and Vav3 act on the small GTPase RhoG. We therefore examined the role of RhoG in the invasive behavior of glioblastoma cells.
Results:
We found that siRNA-mediated depletion of RhoG strongly inhibits invasion of glioblastoma cells through brain slices ex vivo. In addition, depletion of RhoG has a marginal effect on glioblastoma cell proliferation, but significantly inhibits glioblastoma cell survival in colony formation assays. We also observed that RhoG is activated by both HGF and EGF, two factors that are thought to be clinically relevant drivers of glioblastoma invasive behavior, and that RhoG is overexpressed in human glioblastoma tumors versus non-neoplastic brain. In search of a mechanism for the contribution of RhoG to the malignant behavior of glioblastoma cells, we found that depletion of RhoG strongly inhibits activation of the Rac1 GTPase by both HGF and EGF. In line with this observation, we also show that RhoG contributes to the formation of lamellipodia and invadopodia, two functions that have been shown to be Rac1-dependent.
Conclusions:
Our functional analysis of RhoG in the context of glioblastoma revealed a critical role for RhoG in tumor cell invasion and survival. These results suggest that targeting RhoG-mediated signaling presents a novel avenue for glioblastoma therapy.
Insights
Rho GTPase (RhoG) plays a critical role in glioblastoma invasion and survival. Targeting RhoG signaling offers a promising new therapeutic strategy for malignant astrocytomas.
Area of Science:
- Neuro-oncology
- Cellular signaling
- Cancer biology
Background:
- Glioblastoma invasion into normal brain impedes therapy.
- Rho family guanine nucleotide exchange factors Trio and Vav3 influence glioblastoma invasion via RhoG.
- The specific role of RhoG in glioblastoma cell behavior requires further investigation.
Purpose of the Study:
- To investigate the role of RhoG in glioblastoma cell invasion and survival.
- To explore the upstream activators and downstream effectors of RhoG in glioblastoma.
Main Methods:
- Small interfering RNA (siRNA) mediated depletion of RhoG.
- Ex vivo invasion assays using brain slices.
- Cell proliferation and colony formation assays.
- Analysis of GTPase activation by growth factors (HGF, EGF).
- Assessment of lamellipodia and invadopodia formation.
Main Results:
- RhoG depletion significantly inhibited glioblastoma cell invasion.
- RhoG knockdown reduced glioblastoma cell survival but had minimal impact on proliferation.
- RhoG activation was induced by HGF and EGF, and RhoG was overexpressed in glioblastoma tumors.
- RhoG depletion blocked HGF/EGF-induced Rac1 activation and formation of lamellipodia/invadopodia.
Conclusions:
- RhoG is crucial for glioblastoma cell invasion and survival.
- Targeting RhoG-mediated signaling pathways represents a novel therapeutic approach for glioblastoma.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cell Polarization by Rho Proteins
GTPases and their Regulation
Large G-proteins, also known...
The Ras Gene
Ras is a superfamily...
Activation and Inactivation of G Proteins
Cancer Cell Migration through Invadopodia

